- Home
- PDS vs AUTL Comparison
PDS vs AUTL Comparison
Compare PDS & AUTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PDS
- AUTL
- Stock Information
- Founded
- PDS 1951
- AUTL 2014
- Country
- PDS Canada
- AUTL United Kingdom
- Employees
- PDS N/A
- AUTL N/A
- Industry
- PDS
- AUTL Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- PDS
- AUTL Health Care
- Exchange
- PDS Nasdaq
- AUTL Nasdaq
- Market Cap
- PDS 649.5M
- AUTL 625.4M
- IPO Year
- PDS N/A
- AUTL 2018
- Fundamental
- Price
- PDS $51.90
- AUTL $2.52
- Analyst Decision
- PDS Buy
- AUTL Strong Buy
- Analyst Count
- PDS 1
- AUTL 5
- Target Price
- PDS $72.00
- AUTL $9.32
- AVG Volume (30 Days)
- PDS 92.6K
- AUTL 1.5M
- Earning Date
- PDS 07-29-2025
- AUTL 08-12-2025
- Dividend Yield
- PDS N/A
- AUTL N/A
- EPS Growth
- PDS N/A
- AUTL N/A
- EPS
- PDS 5.20
- AUTL N/A
- Revenue
- PDS $1,301,611,298.00
- AUTL $9,011,000.00
- Revenue This Year
- PDS $1.35
- AUTL $471.17
- Revenue Next Year
- PDS $0.99
- AUTL $115.34
- P/E Ratio
- PDS $9.25
- AUTL N/A
- Revenue Growth
- PDS N/A
- AUTL N/A
- 52 Week Low
- PDS $36.20
- AUTL $1.11
- 52 Week High
- PDS $79.07
- AUTL $5.00
- Technical
- Relative Strength Index (RSI)
- PDS 57.75
- AUTL 58.05
- Support Level
- PDS $49.30
- AUTL $2.41
- Resistance Level
- PDS $53.78
- AUTL $2.69
- Average True Range (ATR)
- PDS 1.46
- AUTL 0.15
- MACD
- PDS 0.07
- AUTL -0.01
- Stochastic Oscillator
- PDS 63.78
- AUTL 61.29
About PDS Precision Drilling Corporation
Precision Drilling Corp is a provider of contract drilling and completion and production services to oil and natural gas exploration and production companies in Canada, the United States, and certain international locations. Contract Drilling Services include drilling rigs, procurement and distribution of oilfield supplies, and the manufacture, sale and repair of drilling equipment. Completion and Production Services include service rigs, oilfield equipment rental, and camp and catering services.
About AUTL Autolus Therapeutics plc
Autolus Therapeutics PLC is a biopharmaceutical company developing next-generation programmed T-cell therapies for the treatment of cancer. The company's clinical-stage pipeline comprises Obe-cel (obecabtagene autoleucel), AUTO1/22, AUTO3, AUTO5, AUTO6, AUTO7 & AUTO8.